BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PPARA
,
Response to oxidative stress
,
Influenza
,
Pancreas
,
Laryngoscope
,
Lovastatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nkt cells
(tissue)
Summary
General Info
Body Atlas
Curated Studies
Most Correlated Studies
Mucosal associated invariant T cells of patients after HCT with and without acute GVHD
Blood of infliximab/methotrexate/tocilizumab-treated + immune cells of rheumatoid arthritis patients
Mucosal invariant T cells stimulated with M. bovis and sorted as CD69+ CD26++ or CD69- CD26+/- cells
NKT thymocytes at different stages of maturation
Invariant NKT cells from mice treated with alpha-galactosylceraminde 4wk and 1hr prior to analysis
Explore Curated Studies Results
Literature
Most Relevant Literature
Invariant NKT cells: regulation and function during viral infection.
Isolation and Characterization Methods of Human Invariant NKT Cells.
Cancer Immunotherapy Using Allogeneic NKT Cells].
Genetic Analysis of iNKT Cell Development and Function.
The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor
Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung Cance…
GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblas…
CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ